- Issuer ticker
-
CATX
- Reported as of
-
21 Feb 2023
- Net transaction value
-
$0
Source evidence
Original filing metadata and source links for verification.
4 source fields
- SEC form
-
4
- Accepted by SEC
-
23 Feb 2023, 18:32:10 UTC
Reporting owner
1 detail
- Reporting owner signature
-
/s/ Michael McCormick
Key filing fact
Michael W. McCormick filed Form 4 for Perspective Therapeutics, Inc. (CATX) on 23 Feb 2023.
Key facts
- This page summarizes Michael W. McCormick's Form 4 filing for Perspective Therapeutics, Inc. (CATX).
- 2 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 23 Feb 2023, 18:32.
Change
- Previous filing in this sequence was filed on 29 Jul 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
Ownership activity is grounded in SEC Form 4 disclosures.
View source filing
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CATX
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +470,000
- Change %
- +111%
- Price
-
$0.000000
- Shares after
- 894,615
- Date
- 21 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 470,000
- Exercise price
- $0.3800
- Footnotes
- F1
CATX
transaction
Derivative
Stock Options (right to buy)
Award
- Transaction value
- $0
- Shares
- +230,000
- Change %
- +26%
- Price
-
$0.000000
- Shares after
- 1,124,615
- Date
- 21 Feb 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 230,000
- Exercise price
- $0.3800
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Explanation of responses
2 footnotes